GGrantIndex
Sort

35,931 grants matching parkinsons

DEGRADTION OF SHORT-LIVED REGULATORY PROTEINS IN YEAST

$306,043
Yale University · R01 · FY2003 · GM

Neuronal Mechanisms of Motor Exploration in the Songbird

$306,031
Michale S Fee · Massachusetts Institute Of Technology · R01 · FY2010 · DC

DEGRADTION OF SHORT-LIVED REGULATORY PROTEINS IN YEAST

$306,027
Yale University · R01 · FY2004 · GM

Defining the role of brain iron dysregulation in Huntington's disease

$306,015
Jonathan H Fox · University Of Wyoming · R01 · FY2015 · NS

Soluble aSyn is a modulator of AD pathophysiology

$306,005
Sylvain E. Lesne · University Of Minnesota · R01 · FY2015 · AG

Imaging of Intrinsic Connectivity Networks

$306,002
Nan-Kuei Chen · Duke University · R01 · FY2014 · NS

Regional and Cholinergic Basis of Executive Dysfunction in Parkinson's Disease

$306,000
Daniel Z. Press · Beth Israel Deaconess Medical Center · R01 · FY2009 · MH

Is saccade adaptation driven by reinforcement?

$306,000
Jay A Edelman · City College Of New York · R01 · FY2012 · EY

CRCNS: Computational and experimental study of dopamine and serotonin transporter

$305,999
Jeffry D. Madura · Duquesne University · R01 · FY2010 · DA

Assessment of ultrasound-facilitated neurotherapeutics

$305,973
Elisa E Konofagou · Columbia Univ New York Morningside · R01 · FY2013 · AG

GENE THERAPHY FOR PARKINSON'S DISEASE

$305,960
Children'S Memorial Hospital (Chicago) · R01 · FY2004 · NS

GENE THERAPHY FOR PARKINSON'S DISEASE

$305,960
Children'S Memorial Hospital (Chicago) · R01 · FY2003 · NS

GENE THERAPHY FOR PARKINSON'S DISEASE

$305,960
Children'S Memorial Hospital (Chicago) · R01 · FY2002 · NS

GENE THERAPHY FOR PARKINSON'S DISEASE

$305,960
Children'S Memorial Hospital (Chicago) · R01 · FY2001 · NS

The Biological and Chemical Function of Selenium in Enzymes

$305,952
Robert J Hondal · University Of Vermont & St Agric College · R01 · FY2013 · GM

Glial derived neurotrophic factor for Parkinson's diseas

$305,952
University Of Florida · P01 · FY2004 · NS

Vulnerability to neuroinflammation of brainstem ascending aminergic systems

$305,940
Gary L. Wenk · Ohio State University · R01 · FY2012 · AG

Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders

$305,930
Eugenia Trushina · Mayo Clinic Rochester · R01 · FY2012 · ES

Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders

$305,930
Eugenia Trushina · Mayo Clinic Rochester · R01 · FY2015 · ES

Mitochondrial dynamics and metabolomic biomarkers in neurodegenerative disorders

$305,930
Eugenia Trushina · Mayo Clinic Rochester · R01 · FY2011 · ES

Differential modes of cholinergic transmission onto cellular hippocampal targets

$305,911
John Joshua Lawrence · University Of Montana · R01 · FY2011 · NS

The Mechanism of LRRK2-Mediated Neurodegneration in Parkinson's Disease

$305,910
William T Dauer · University Of Michigan At Ann Arbor · R01 · FY2010 · NS

Mechanisms of airway protection dysfunction in Parkinson's disease

$305,889
Karen W Hegland · University Of Florida · R01 · FY2017 · HD

Ultrastructural Basis of Neurochemical Measures in Brain

$305,866
Adrian C. Michael · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · MH

Development of a gene edited platform to enable human allogeneic cell replacement therapy

$305,855
Christopher Shen · Aleutian Therapeutics, Inc. · R41 · FY2025 · AI